Santhera Pharmaceuticals (0QN1.LSE) Q2 2025 Earnings

29AprConfirmed
Q2 2023
Q2 2024
Q3 2024
Q2 2025
-1.9
-1.26
-0.63
-0

Details

Expected EPS
N/A
Actual EPS
-1.895292417348
Surprise EPS
-1.9
Surprise Percent
+∞%

Description

Santhera Pharmaceuticals (0QN1.LSE) has reported earnings of -1.895292417348 per share for Q2 2025.

0 Comments

Share your thoughts